|
BCL9L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.840430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.784050E-01 |
| Normal-vs-Stage2 |
2.563100E-03 |
| Normal-vs-Stage3 |
4.830400E-01 |
| Normal-vs-Stage4 |
9.763200E-01 |
| Stage1-vs-Stage2 |
2.799500E-02 |
| Stage1-vs-Stage3 |
5.593200E-01 |
| Stage1-vs-Stage4 |
2.049400E-01 |
| Stage2-vs-Stage3 |
1.586400E-02 |
| Stage2-vs-Stage4 |
4.415800E-03 |
| Stage3-vs-Stage4 |
5.554000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.338400E-01 |
| Normal-vs-AfricanAmerican |
5.351000E-01 |
| Normal-vs-Asian |
6.712400E-01 |
| Caucasian-vs-AfricanAmerican |
9.298800E-01 |
| Caucasian-vs-Asian |
2.186600E-01 |
| AfricanAmerican-vs-Asian |
3.891200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339440E-01 |
| Normal-vs-Female |
2.352000E-01 |
| Male-vs-Female |
5.055800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.762400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.164200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.785990E-02 |
| Normal-vs-Age(81-100Yrs) |
7.706200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.819200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.422200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.500000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.754640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.710200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.812200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.009400E-01 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
8.085900E-02 |
| Classical-VS-Normal |
8.986400E-01 |
| Tall-VS-Follicular |
2.37279999999451E-05 |
| Tall-VS-Other |
9.564000E-02 |
| Tall-VS-Normal |
4.081000E-01 |
| Follicular-VS-Other |
2.753800E-01 |
| Follicular-VS-Normal |
1.42360001564867E-09 |
| Other-VS-Normal |
8.817600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.024400E-02 |
| Normal-vs-N1 |
4.726800E-01 |
| N0-vs-N1 |
1.444210E-01 |
|
|
